166 related articles for article (PubMed ID: 37626910)
1. Increased Actin Binding Is a Shared Molecular Consequence of Numerous SCA5 Mutations in β-III-Spectrin.
Atang AE; Keller AR; Denha SA; Avery AW
Cells; 2023 Aug; 12(16):. PubMed ID: 37626910
[TBL] [Abstract][Full Text] [Related]
2. Increased actin binding is a shared molecular consequence of numerous spinocerebellar ataxia mutations in β-III-spectrin.
Atang AE; Keller AR; Denha SA; Avery AW
bioRxiv; 2023 Apr; ():. PubMed ID: 36865188
[TBL] [Abstract][Full Text] [Related]
3. A human β-III-spectrin spinocerebellar ataxia type 5 mutation causes high-affinity F-actin binding.
Avery AW; Crain J; Thomas DD; Hays TS
Sci Rep; 2016 Feb; 6():21375. PubMed ID: 26883385
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for high-affinity actin binding revealed by a β-III-spectrin SCA5 missense mutation.
Avery AW; Fealey ME; Wang F; Orlova A; Thompson AR; Thomas DD; Hays TS; Egelman EH
Nat Commun; 2017 Nov; 8(1):1350. PubMed ID: 29116080
[TBL] [Abstract][Full Text] [Related]
5. Novel drug discovery platform for spinocerebellar ataxia, using fluorescence technology targeting β-III-spectrin.
Rebbeck RT; Andrick AK; Denha SA; Svensson B; Guhathakurta P; Thomas DD; Hays TS; Avery AW
J Biol Chem; 2021; 296():100215. PubMed ID: 33839680
[TBL] [Abstract][Full Text] [Related]
6. β-III-spectrin spinocerebellar ataxia type 5 mutation reveals a dominant cytoskeletal mechanism that underlies dendritic arborization.
Avery AW; Thomas DD; Hays TS
Proc Natl Acad Sci U S A; 2017 Oct; 114(44):E9376-E9385. PubMed ID: 29078305
[TBL] [Abstract][Full Text] [Related]
7. Early-phase drug discovery of β-III-spectrin actin-binding modulators for treatment of spinocerebellar ataxia type 5.
Guhathakurta P; Rebbeck RT; Denha SA; Keller AR; Carter AL; Atang AE; Svensson B; Thomas DD; Hays TS; Avery AW
J Biol Chem; 2023 Mar; 299(3):102956. PubMed ID: 36731793
[TBL] [Abstract][Full Text] [Related]
8. β-III-spectrin N-terminus is required for high-affinity actin binding and SCA5 neurotoxicity.
Denha SA; Atang AE; Hays TS; Avery AW
Sci Rep; 2022 Feb; 12(1):1726. PubMed ID: 35110634
[TBL] [Abstract][Full Text] [Related]
9. Beta-III spectrin mutation L253P associated with spinocerebellar ataxia type 5 interferes with binding to Arp1 and protein trafficking from the Golgi.
Clarkson YL; Gillespie T; Perkins EM; Lyndon AR; Jackson M
Hum Mol Genet; 2010 Sep; 19(18):3634-41. PubMed ID: 20603325
[TBL] [Abstract][Full Text] [Related]
10. Spinocerebellar ataxia type 5.
Dick KA; Ikeda Y; Day JW; Ranum LP
Handb Clin Neurol; 2012; 103():451-9. PubMed ID: 21827906
[TBL] [Abstract][Full Text] [Related]
11. Infantile-onset spinocerebellar ataxia type 5 associated with a novel SPTBN2 mutation: A case report.
Mizuno T; Kashimada A; Nomura T; Moriyama K; Yokoyama H; Hasegawa S; Takagi M; Mizutani S
Brain Dev; 2019 Aug; 41(7):630-633. PubMed ID: 30898343
[TBL] [Abstract][Full Text] [Related]
12. Spectrin mutations that cause spinocerebellar ataxia type 5 impair axonal transport and induce neurodegeneration in Drosophila.
Lorenzo DN; Li MG; Mische SE; Armbrust KR; Ranum LP; Hays TS
J Cell Biol; 2010 Apr; 189(1):143-58. PubMed ID: 20368622
[TBL] [Abstract][Full Text] [Related]
13. A family with spinocerebellar ataxia type 5 found to have a novel missense mutation within a SPTBN2 spectrin repeat.
Cho E; Fogel BL
Cerebellum; 2013 Apr; 12(2):162-4. PubMed ID: 22843192
[TBL] [Abstract][Full Text] [Related]
14. Mutant β-III spectrin causes mGluR1α mislocalization and functional deficits in a mouse model of spinocerebellar ataxia type 5.
Armbrust KR; Wang X; Hathorn TJ; Cramer SW; Chen G; Zu T; Kangas T; Zink AN; Öz G; Ebner TJ; Ranum LP
J Neurosci; 2014 Jul; 34(30):9891-904. PubMed ID: 25057192
[TBL] [Abstract][Full Text] [Related]
15. Screening of the SPTBN2 (SCA5) gene in German SCA patients.
Zühlke C; Bernard V; Dalski A; Lorenz P; Mitulla B; Gillessen-Kaesbach G; Bürk K
J Neurol; 2007 Dec; 254(12):1649-52. PubMed ID: 17940722
[TBL] [Abstract][Full Text] [Related]
16. Expanding the β-III Spectrin-Associated Phenotypes toward Non-Progressive Congenital Ataxias with Neurodegeneration.
Sancho P; Andrés-Bordería A; Gorría-Redondo N; Llano K; Martínez-Rubio D; Yoldi-Petri ME; Blumkin L; Rodríguez de la Fuente P; Gil-Ortiz F; Fernández-Murga L; Sánchez-Monteagudo A; Lupo V; Pérez-Dueñas B; Espinós C; Aguilera-Albesa S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801522
[TBL] [Abstract][Full Text] [Related]
17. Recessive mutations in SPTBN2 implicate β-III spectrin in both cognitive and motor development.
Lise S; Clarkson Y; Perkins E; Kwasniewska A; Sadighi Akha E; Schnekenberg RP; Suminaite D; Hope J; Baker I; Gregory L; Green A; Allan C; Lamble S; Jayawant S; Quaghebeur G; Cader MZ; Hughes S; Armstrong RJ; Kanapin A; Rimmer A; Lunter G; Mathieson I; Cazier JB; Buck D; Taylor JC; Bentley D; McVean G; Donnelly P; Knight SJ; Jackson M; Ragoussis J; Németh AH
PLoS Genet; 2012; 8(12):e1003074. PubMed ID: 23236289
[TBL] [Abstract][Full Text] [Related]
18. Spectrin mutations cause spinocerebellar ataxia type 5.
Ikeda Y; Dick KA; Weatherspoon MR; Gincel D; Armbrust KR; Dalton JC; Stevanin G; Dürr A; Zühlke C; Bürk K; Clark HB; Brice A; Rothstein JD; Schut LJ; Day JW; Ranum LP
Nat Genet; 2006 Feb; 38(2):184-90. PubMed ID: 16429157
[TBL] [Abstract][Full Text] [Related]
19. Two novel missense variants in SPTBN2 likely associated with spinocerebellar ataxia type 5.
Bian X; Wang S; Jin S; Xu S; Zhang H; Wang D; Shang W; Wang P
Neurol Sci; 2021 Dec; 42(12):5195-5203. PubMed ID: 33797620
[TBL] [Abstract][Full Text] [Related]
20. Progressive SCAR14 with unclear speech, developmental delay, tremor, and behavioral problems caused by a homozygous deletion of the SPTBN2 pleckstrin homology domain.
Yıldız Bölükbaşı E; Afzal M; Mumtaz S; Ahmad N; Malik S; Tolun A
Am J Med Genet A; 2017 Sep; 173(9):2494-2499. PubMed ID: 28636205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
